Amedica (AMDA) priced an underwritten public offering for gross proceeds of US $11MM, prior to various deductions (e.g., underwriting discounts, commissions and offering expenses). Closing is expected to occur by 7/8/16.
Net proceeds will support R&D/clinical trials, commercialization of product candidates, sales/marketing distribution of silicon nitride products, repayment of notes, etc.
The offering comprises Class A and B Units, priced at $1.00 and $1,000 per unit, respectively. A total of 3,608,000 shares of common stock, 7,392 shares of preferred stock convertible into 7,392,000 shares of common stock and warrants to purchase 11,000,000 shares of common stock will be issued.
AMDA is awaiting approval from FDA to commence U.S. marketing its composite silicon nitride spinal interbody device.
Sources: Amedica Corporation press release, Form S-1 on SEC.gov; ORTHOWORLD Inc.
Amedica (AMDA) priced an underwritten public offering for gross proceeds of US $11MM, prior to various deductions (e.g., underwriting discounts, commissions and offering expenses). Closing is expected to occur by 7/8/16.
Net proceeds will support R&D/clinical trials, commercialization of product candidates, sales/marketing distribution of...
Amedica (AMDA) priced an underwritten public offering for gross proceeds of US $11MM, prior to various deductions (e.g., underwriting discounts, commissions and offering expenses). Closing is expected to occur by 7/8/16.
Net proceeds will support R&D/clinical trials, commercialization of product candidates, sales/marketing distribution of silicon nitride products, repayment of notes, etc.
The offering comprises Class A and B Units, priced at $1.00 and $1,000 per unit, respectively. A total of 3,608,000 shares of common stock, 7,392 shares of preferred stock convertible into 7,392,000 shares of common stock and warrants to purchase 11,000,000 shares of common stock will be issued.
AMDA is awaiting approval from FDA to commence U.S. marketing its composite silicon nitride spinal interbody device.
Sources: Amedica Corporation press release, Form S-1 on SEC.gov; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.